Leverage CBRE’s industry leading life sciences platform to access the deepest and most aggressive pool of investment capital for an array of investment opportunities within Maryland’s BioTech Corridor.
We See Every Deal
Q1 2022 Maryland Life Sciences Report
Read our Q1 report highlighting how a historic 2021 set the stage for a prolific start to the new year — where demand continues to outpace supply.
Read ReportGet Quarterly Insights
You'll get access to the best opportunities and our boots-on-the-ground local insights.
Life Sciences Insights & Research
- Brief | Intelligent Investment
Despite the Cost, Construction of Life Sciences Properties Brings Strong Returns
April 21, 2022 2 Minute Read
Although a costly proposition, investors are realizing strong returns on newly built life sciences properties or those that are converted from other uses.
The I-270 Life Science Market’s Breakout Year While already established as a top-5 life science cluster, 2021 will be remembered as the year that the Maryland ...
- Report | Adaptive Spaces
Biotech Revolution Accelerates Demand for Lab Space
Driven by biotechnology and other advancements, the U.S. life sciences industry continues to shatter records for employment and venture capital funding.
- Report | Intelligent Investment
U.S. Real Estate Market Outlook 2022: Life Science
Demand for office space will bounce back as more workers return to the office and occupiers take advantage of favorable market conditions.
- Figures
U.S. Life Sciences Trends 2021
Local Expertise,
Global Reach
We provide the life sciences industry solutions that maximize facility and investment performance across labs, manufacturing space and critical environments.
Our Expertise
We're Here. Let's Get Started.
Our team is here – working hand in hand with the industry leaders fueling the rapid Life Sciences sector growth in Maryland.
- Industry leading market intelligence within an opaque asset class
- Real time insight gleaned from our unrivaled work with pharmaceutical, biotech, genomic, contract research and contract manufacturing organizations
- Technical expertise and innovative sustainable operation of highly critical research and manufacturing environments
We connect capital with opportunity by sourcing all portions of the capital stack for Maryland's most sought-after projects. Our market leading activity gives us unique perspective to help our clients make informed decisions.
- Assisting investors and developers in the monetization of their owned assets
- Structuring equity including co-GP, preferred, and LP capital for new development
- Providing innovative financing solutions driven by distinct subject matter expertise
Success Stories
Making Headlines
- Article
No longer emerging, it’s here: 3 key factors driving record growth in Maryland’s life sciences market
March 11, 2022
The biotechnology industry is booming in the U.S., creating a hot market for laboratories and other specialty properties.
Horizon Therapeutics plc announced today that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. to be the first tenant at the Alexandria Center®...
CBRE arranged the recent sale of three office/flex properties to Thor Equities for $45 million. The properties are located at 20, 30 and 50 West Gude Drive in R...
- Press Release
Lantian Development Completes Sale of Shady Grove Bio+Tech Campus to Boston Properties for $116.5M
August 2, 2021
Lantian Development, a full-service real estate investment and development company headquartered in Bethesda, Maryland, completed the sale of its Shady Grove Bi...
